Asia’s pharma markets are extremely complex with each country governed by very different healthcare policies, reimbursement schemes, unique pricing, with large risks involved in entering the market, particularly with high priced, specialty drugs/therapeutics. Once way is to overcome this is to out-license, which cuts risks but can also decrease profits. There is also no guarantee that this will lead to success.

3rd Annual Pharma Market Access Asia 2017 brings pharma and industry together to navigate the complex environments and lessons learnt from successfully and profitable market entries for orphan drugs, high priced therapeutics, generics, biosimilars and more.

“Excellent event! Looking at multiple perspective from patients, policy maker, prescriber, provider, and payers. Well done to the producer and organizing team!”
Sebastien Boisseau, Market Access Director, Mundipharma

Conference Highlights:

  • Country Case Studies - On market access by Pharma companies
  • Growth Markets and Strategy Spotlight for Biosimilars, Generics, Orphan drugs, etc
  • Pricing and Reimbursement - Strategies for improving market access
  • Leveraging HEOR and RWE - In support of Market Access
  • Out Licensing and Partnerships - For successful collaboration models

Thought Leadership Keynote

From Trials to Table – The Move Towards a More Patient-Centric Approach 
John Wilbanks
Chief Commons Officer, Sage Bionetworks, Senior Fellow
Ewing Marion Kauffman Foundation and FasterCures, USA
TEDGlobal 2012 Speaker on “Let’s Pool Our Medical Data” 
View John’s talk at TEDGlobal 2012 [here]

Featured Speakers

Tay Salimullah
Global Strategic Projects Leader, Real World Evidence, Novartis Pharma AG, Switzerland

Qing Xi
Head of Government Affairs, Market Access & Communications, Pfizer, China

Anh Bourcet
Associate Director, ASPAC Health Economic & Market Access, Orthopedics, Johnson & Johnson, Singapore

Sittipong Liamsuwan
Policy & Market Access Director, MSD (Thailand) Ltd., Thailand

Megan Kim
Head of Market Access Korea, Boehringer Ingelheim Pte Ltd, Korea

Jean-François Baladi
Senior Executive, Health Economics and Market Access, Novartis Pharma K.K., Japan

Enrique A. Tayag
Assistant Secretary, Office for Policy and Health Systems, Department of Health, Philippines

Part of


Co-Located Events

Past Audience Reviews

“The speakers were very knowledgeable about the subject matter that they cover, and I left the conference with valuable information about the business.”

Redentor R. Romero,
Compliance Director for AsiaPac, Teva Pharmaceutical Investments

“Networking opportunity was excellent. I am already bringing contacts back to my company. I also gained great insights into product registration in Asia.”

Elaine Wang,
Director, BIPI

“Good networking opportunities with amazing people in the industry. This is my first conference and looking forward for more.”

Nur Farhana Muhamad
, Market Analyst, Pharmaniaga Berhad

“Many interesting topics were presented in the conference. Met regulatory affairs from various companies across Asia and exchanged information regarding issues we have faced in registering the product.”

Astuti Kurniati
, Associate Principal Regulatory Specialist, PT Dexa Medica

“This was a fantastic gathering and a very well organized event. Would love to attend this in the future. Keep up the good work”

Rahul Mongia
, Research Associate, ICRIER

“High quality speakers - Strategic inputs valuable for my day today”

Astrazeneca

“Very interactive with case based learning approaches”

Abbott Healthcare

Contact Us

Produced by

Associate Sponsors

Session Spotlight Sponsors

Sponsor

Supporting Associations